John Danesh

John Danesh is Professor of Epidemiology and Medicine and Head of the Department of Public Health and Primary Care at the University of Cambridge. He concurrently serves as a Faculty Member at the Wellcome Sanger Institute, Honorary Consultant at Cambridge University Hospital NHS Foundation Trust (Addenbrooke's Hospital), Professorial Fellow at Jesus College, Cambridge, Founder-Director of the Cardiovascular Epidemiology Unit, and Director of Health Data Research UK-Cambridge.

His research spans cardiovascular epidemiology, genetic determinants of disease, and health data science. He pioneers the integration of genomics, metabolomics, and large-scale population data to unravel disease mechanisms, with emphasis on polygenic risk scores, metabolite-disease associations, and international collaborations like the BELIEVE cohort in Bangladesh. His work bridges molecular biology with public health applications for precision prevention.

Analysis of his 2022-2025 publications reveals dominant themes in multi-omics cardiovascular risk prediction, including genetic architecture of coronary disease, iron homeostasis pathways, and regional risk variations in South Asian populations. Key methodologies involve individual-participant-data meta-analyses, Mendelian randomization, and computational modeling of biological networks.

Scientific Awards:

• No specific awards listed in source materials

Professor Danesh leads major grant-funded initiatives including the Cardiovascular Epidemiology Unit and Health Data Research UK-Cambridge. His advisory roles in national health data infrastructure and longitudinal research environments demonstrate significant influence in shaping large-scale epidemiological studies and translational data science applications.

He directs the Cambridge Mathematics of Information in Healthcare (CMIH) hub, fostering cross-disciplinary teams that apply advanced computational methods to healthcare data. His laboratory focuses on genetic and metabolic drivers of cardiovascular disease through international cohort studies and innovative risk prediction modeling.